Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Ribback

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Cancers|November 13, 2021
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and SenescenceLaura Schreyer, Constanze Mittermeier, Miriam J Franz, et al.
BMC Medicine|October 4, 2019
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohortTobias Klatte, Kevin M Gallagher, Luca Afferi, et al.
Journal of Hepatology|June 14, 2019
Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesisJingxiao Wang, Haichuan Wang, Michele Peters, et al.
Hepatology (Baltimore, Md.)|February 25, 2016
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humansLei Li, Li Che, Kevin M Tharp, et al.
Cancer Research|November 29, 2017
Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic CancerJennifer Brooks, Bettina Fleischmann-Mundt, Norman Woller, et al.
The American Journal of Pathology|February 23, 2019
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human HepatoblastomaJie Zhang, Pin Liu, Junyan Tao, et al.
Angiogenesis|June 6, 2025
High-throughput differentiation of human blood vessel organoids reveals overlapping and distinct functions of the cerebral cavernous malformation proteinsDariush Skowronek, Robin A Pilz, Valeriia V Saenko, et al.
Gut|May 20, 2016
Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancerUjjwal M Mahajan, Steffen Teller, Matthias Sendler, et al.
Journal of Hepatology|May 30, 2021
Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activationXinhua Song, Hongwei Xu, Pan Wang, et al.
Journal of Hepatology|October 18, 2015
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humansLei Li, Giulia M Pilo, Xiaolei Li, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Cancers|November 13, 2021
Tetraspanin 5 (TSPAN5), a Novel Gatekeeper of the Tumor Suppressor DLC1 and Myocardin-Related Transcription Factors (MRTFs), Controls HCC Growth and SenescenceLaura Schreyer, Constanze Mittermeier, Miriam J Franz, et al.
BMC Medicine|October 4, 2019
The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohortTobias Klatte, Kevin M Gallagher, Luca Afferi, et al.
Journal of Hepatology|June 14, 2019
Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesisJingxiao Wang, Haichuan Wang, Michele Peters, et al.
Hepatology (Baltimore, Md.)|February 25, 2016
Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humansLei Li, Li Che, Kevin M Tharp, et al.
Cancer Research|November 29, 2017
Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic CancerJennifer Brooks, Bettina Fleischmann-Mundt, Norman Woller, et al.
The American Journal of Pathology|February 23, 2019
TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human HepatoblastomaJie Zhang, Pin Liu, Junyan Tao, et al.
Angiogenesis|June 6, 2025
High-throughput differentiation of human blood vessel organoids reveals overlapping and distinct functions of the cerebral cavernous malformation proteinsDariush Skowronek, Robin A Pilz, Valeriia V Saenko, et al.
Gut|May 20, 2016
Tumour-specific delivery of siRNA-coupled superparamagnetic iron oxide nanoparticles, targeted against PLK1, stops progression of pancreatic cancerUjjwal M Mahajan, Steffen Teller, Matthias Sendler, et al.
Journal of Hepatology|May 30, 2021
Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activationXinhua Song, Hongwei Xu, Pan Wang, et al.
Journal of Hepatology|October 18, 2015
Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humansLei Li, Giulia M Pilo, Xiaolei Li, et al.
Pageof 10